Altimmune (ALT) Financials

$3.42

$0.19 (5.88%)

As on 04-Sep-2026 16:26EDT

Market cap

$605 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

1.3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	0.03	0.04	0.02	0.43	-0.07	4.41
Cost of Revenue	15.03	0.11	0.24	0.48	0.50	73.84
Gross Profit	-14.98	0.04	0.02	0.43	-0.07	4.41
Operating Expenses	85.27	94.53	103.19	96.36	87.67	101.32
Operating Profit (EBIT)	-100.23	-94.49	-103.17	-95.93	-87.74	-96.91
Other Income	--	--	--	--	--	-0.17
Profit before Tax	-91.76	-88.77	-95.06	-88.45	-84.91	-97.09
Provision for Tax	--	-0.68	--	0.31	-0.20	-0.92
Profit after Tax (Net Income)	-91.76	-88.09	-95.06	-88.45	-84.71	-97.09
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-84.71	-97.09

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	474.21	224.89	123.51	194.10	185.29	199.13
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	40.50	40.04	5.33	4.40	4.58	1.45
Current Liabilities	12.50	15.00	10.47	12.14	17.05	18.28
Total Liabilities	539.71	279.93	139.31	210.64	206.93	218.86

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	192.40	1.74	2.05	1.01	14.12	14.74
Current Assets	334.82	278.19	137.25	209.63	192.81	204.13
Total Assets	862.03	279.93	139.31	210.64	206.93	218.86
Total Debt*	35.75	35.69	1.68	0.67	1.12	1.87
Net Current Assets	--	263.20	126.79	197.48	175.76	185.85

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-67.54	-79.85	-75.81	-62.59	-78.24
Cash Flow from Investing Activities	--	-132.47	-28.39	13.73	-73.40	87.52
Cash from Financing Activities	--	206.84	10.04	86.11	56.78	65.10
Net Cash Inflow / Outflow	--	--	--	--	--	74.38

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.79	-0.88	-1.33	-1.51	-1.69	-2.33
Cash EPS ($)	--	-0.87	-1.33	-1.51	-1.70	-2.31
Adjusted Book Value ($)	--	2.24	1.73	3.32	3.70	4.77
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.67	-1.12	-1.30	-1.25	-1.88
Free Cash Flow per Share ($)	--	-0.67	-1.12	-1.30	-1.25	-2.17

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-45.67	-59.42	-46.41	-43.73	-45.26
ROE (%)	-26.25	-50.57	-59.86	-46.63	-44.07	-45.69
ROA (%)	-17.29	-42.03	-54.33	-42.36	-39.79	-41.85
EBIT Margin (%)	-299,106.45	-212,531.71	-475,250.00	-20,753.99	124,855.88	-2,201.47
Net Margin (%)	-296,000.00	-214,860.98	-475,295.00	-20,762.21	124,577.94	-2,290.47
Cash Profit Margin (%)	-3.89	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	55.00	1.05	-0.95	7.26	-1.02	-0.46
EBIT Growth (%)	-5.18	8.32	-7.51	-4.13	12.55	-151.95
Net Profit Growth (%)	-4.57	7.33	-7.48	-4.41	12.75	-97.96
EPS Growth (%)	33.00	0.34	0.12	0.11	0.27	-0.85
Book Value Growth (%)	29.12	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-4.12	-5.40	-7.43	-9.71	-3.93
Price / Book Value	1.33	1.62	4.16	3.39	4.44	1.92
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	11.93	-1.44	-4.05	-5.23	-7.57	-2.01
Close Price ($)	3.04	3.61	7.21	11.25	16.45	9.16
High Price ($)	6.44	7.83	14.84	17.17	23.49	24.61
Low Price ($)	2.56	2.90	5.28	2.09	3.83	8.10
Market Cap ($ Cr)	604.95	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.16	0.01	0.00	0.01	0.01
Short term debt to equity ratio	--	0.00	0.00	0.00	0.00	0.00
Current Ratio	26.78	18.55	13.11	17.26	11.31	11.17
Quick Ratio	26.78	--	--	--	11.30	743.75
Interest Coverage	-24.95	-53.26	-10,561.11	-2,526.06	-10,612.75	-19,417.00

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	10,777.42	4,236.59	15,585.00	1,139.20	-3,736.76	132.39
Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.02
Receivable days	--	21,621.02	72,776.06	3,169.79	-22,504.44	754.17
Inventory Days	--	--	--	26.03	-4,890,143.10	-37,957.50
Payable days	--	4,774.34	1,750.28	2,631.79	2,497.76	6.55
Cash Conversion Cycle	--	--	--	564.03	-4,915,145.30	-37,209.88

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.